Surreal illustration of a heart with calcified arteries linked to a dialysis machine, symbolizing hope for hemodialysis patients.

Hidden Culprit? How Coronary Artery Calcification Could Threaten Dialysis Access

Kai Mendoza monogram
Kai Mendoza in Health & Wellness November 2026 • 4 min read.

"New research reveals how coronary artery calcification predicts microcalcification of vascular access in hemodialysis patients, offering a crucial insight for better patient care."


For individuals undergoing hemodialysis, maintaining reliable vascular access is critical for treatment. However, the longevity and health of these access points can be compromised by a phenomenon known as arterial micro-calcification (AMC). AMC not only threatens the patency of vascular access but also poses a risk to cardiovascular health, making it a significant concern for both patients and healthcare providers.

While AMC is typically diagnosed through invasive histologic examination, a new avenue of investigation has emerged, focusing on coronary artery calcification (CAC). CAC is a common cardiovascular risk factor easily detected through noninvasive computed tomography. A recent study explored whether CAC could serve as a predictor for AMC in hemodialysis patients, potentially offering a less invasive method for risk assessment.

This article delves into the findings of this pivotal research, highlighting the correlation between CAC and AMC in non-diabetic hemodialysis patients. By understanding this connection, healthcare professionals can proactively monitor and manage vascular access health, ultimately improving patient outcomes and quality of life.

AI Search Multiple angles on this topic

Tracking CAC Across Kidney Replacement Treatments

Jansz TT and colleagues investigated how coronary artery calcification (CAC) progresses among patients receiving conventional hemodialysis, nocturnal hemodialysis, and kidney transplantation. The source identifies progression across these treatment groups as the study’s focus but provides no numerical results or comparative findings. Its description therefore does not establish which treatment group experienced faster progression or quantify the impact.

Unveiling the Connection: CAC as a Predictor of AMC

Surreal illustration of a heart with calcified arteries linked to a dialysis machine, symbolizing hope for hemodialysis patients.

The study, spearheaded by Young Ok Kim, Bomi Choi, Young Soo Kim, and Ho Cheol Song, focused on forty non-diabetic patients undergoing hemodialysis who had received vascular access operations. The researchers sought to determine if the extent of coronary artery calcification, measured by the coronary artery calcium score (CACS), could predict the presence of AMC in these patients.

Patients underwent multi-detector computed tomography (MDCT) imaging to calculate their CACS. Based on their scores, participants were divided into two groups: those with low CACS (<100) and those with high CACS (≥100). The presence of AMC was confirmed through pathologic examination of arterial specimens obtained during vascular access surgery, using von Kossa staining.

  • Study Population: 40 non-diabetic patients receiving hemodialysis.
  • AMC Diagnosis: Pathologic examination via von Kossa stain.
  • CAC Assessment: Multi-detector computed tomography (MDCT).
  • CACS Groups: Low CACS (<100) and High CACS (≥100).
AI Search Multiple angles on this topic

Measuring CAC and Its Changing Risk

A study published January 1, 2025, addresses whether changes in coronary artery calcification (CAC) over time affect risk, an area the authors say is less understood for people with kidney disease than CAC’s association with heart disease and death. Another study describes calculating coronary artery calcium scores (CACS) with the Agatston method, with board-certified diagnostic radiologists blinded to participants’ identities. A March 6, 2026, study examines whether albumin-corrected calcium and ionized calcium measured when hemodialysis begins are associated with CACS; its source says this relationship remains unclear. A July 20, 2026, study assesses risk factors for vascular calcification in people receiving maintenance hemodialysis.

Comparing Hemodialysis and Peritoneal Dialysis

A study published April 1, 2011, set out to compare coronary artery calcification scores (CACS) in peritoneal dialysis (PD) and hemodialysis (HD) patients and assess the effect of dialysis over 12 months. A separate study, published November 13, 2018, compared CAC, its progression, and calcification biomarkers between patients receiving HD and PD. The supplied descriptions establish that both studies examined differences between the two dialysis modalities, but provide no results with which to say whether CAC burden or progression differed.

The results revealed a significant association between high CACS and the presence of AMC. Patients in the high CACS group were generally older and exhibited a higher incidence of AMC compared to the low CACS group. Specifically, high CACS was independently associated with positive AMC, indicating that the extent of coronary artery calcification could indeed predict the likelihood of microcalcification in vascular access.

Implications for Hemodialysis Patients: A Path Forward

This research underscores the importance of monitoring coronary artery calcification in hemodialysis patients as a predictor of vascular access complications. By integrating CACS assessment into routine evaluations, healthcare providers can identify high-risk individuals and implement targeted interventions to preserve vascular access health. Further studies are needed to explore optimal strategies for managing CAC and preventing AMC, potentially improving long-term outcomes for patients undergoing hemodialysis.

AI Search Multiple angles on this topic

CAC, Bone Markers, and Cardiovascular Risk

A study published August 15, 2023, examined factors associated with CAC in people receiving maintenance hemodialysis and its relationship with bone-metabolism markers, aiming to identify a marker linking vascular calcification and bone metabolism. A separate cohort study assessed the prospective association between CAC and cardiovascular disease and all-cause mortality among dialysis-naive adults with chronic kidney disease recruited from seven U.S. clinical centers. A March 22, 2022, study focused on the prevalence and impact of CAC among hemodialysis patients with coronary artery disease who underwent percutaneous coronary intervention. The supplied descriptions state these research questions but do not provide results to resolve them.

Assessing CAC Burden in Hemodialysis

A study published March 6, 2021, evaluated CAC burden and its association with clinical and laboratory parameters in asymptomatic patients who had recently started hemodialysis, considering CAC scoring as a possible predictor of future cardiovascular events. A February 23, 2026, chapter reports that arterial calcification reduces arterial compliance and increases pulse wave velocity, elevating left ventricular afterload. It also reports that CAC scores in hemodialysis patients are 10–30 times higher than in the general population and strongly correlate with all-cause and cardiovascular mortality. These findings frame CAC assessment as a research and risk-assessment focus, while the supplied sources do not establish how well scoring guides future care.

CAC and Blood-Pressure Changes During Dialysis

A study of 36 people with end-stage renal disease receiving maintenance hemodialysis examined the relationship between coronary artery calcium scores and intradialytic blood-pressure abnormalities. Participants had nongated chest computed tomography scans. A separate clinical trial compared the non-calcium phosphate binder sevelamer hydrochloride with calcium-containing phosphate binders in people new to hemodialysis; the supplied summary reports CAC progression among patients whose baseline CAC was above 30. These descriptions identify blood-pressure changes during treatment and calcification progression as studied concerns, but do not provide enough information to quantify patient-level effects or compare treatment outcomes.

CAC prevalence in hemodialysis

  • 24%–93%; pooled 65% %Across the included reports, CAC prevalence ranged from 24% to 93%; the pooled estimate was 65%.[1]

What calcification at the access site may signal

In advanced kidney disease, mineral burdens and changes in vascular smooth muscle cells are described as part of the setting in which vascular calcification develops.[2]

Another report states that arterial microcalcification does not explain several access outcomes, including stenosis, failure to mature, or failure after successful cannulation. This limits how far access calcification alone can be taken as an explanation for access problems.[3]

Clinical guidance describes radiography and echocardiography as reasonable alternatives to CT-based imaging for detecting vascular or valvular calcification in people with CKD G3a–G5D, and places those with known calcification in the highest cardiovascular-risk category.[4]

What remains unresolved about access calcification

  • How can a possible systemic signal be distinguished from a direct explanation of access problems, given reports that microcalcification does not explain several access outcomes?[2] [3]

Sources

  1. Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis (pmc.ncbi.nlm.nih.gov)
  2. Quantified Vascular Calcification at the Dialysis Access Site: Correlations with the Coronary Artery Calcium Score and Survival Analysis of Access and Cardiovascular Outcomes (pmc.ncbi.nlm.nih.gov)
  3. Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysis. (pubmed.ncbi.nlm.nih.gov)
  4. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is arterial microcalcification (AMC), and why is it a problem?

Arterial microcalcification (AMC) refers to the buildup of calcium deposits in the arteries, specifically those used for vascular access in hemodialysis patients. This is a critical concern because it can lead to the narrowing or blockage of these access points, making hemodialysis treatment difficult or impossible. AMC also poses cardiovascular risks, emphasizing the importance of understanding and managing this condition. Diagnosing AMC typically involves invasive histologic examination but this study explored a less invasive method by looking at Coronary Artery Calcification (CAC).

2

What is coronary artery calcification (CAC) and how is it related to vascular health?

Coronary artery calcification (CAC) is the buildup of calcium in the arteries of the heart. It's a common indicator of cardiovascular risk and can be easily detected through non-invasive methods like computed tomography. This research found a link between CAC, measured by the coronary artery calcium score (CACS) and arterial microcalcification (AMC) in hemodialysis patients. The significance lies in using CAC as a predictor for AMC. This offers a less invasive way to assess the risk of AMC, which threatens vascular access health, allowing for earlier intervention and potentially improving patient outcomes.

3

How was the study conducted, and what methods were used to assess patients?

The study involved 40 non-diabetic patients undergoing hemodialysis. The researchers assessed each patient's Coronary Artery Calcification (CAC) using multi-detector computed tomography (MDCT) to determine the coronary artery calcium score (CACS). Patients were then categorized into low CACS (<100) and high CACS (≥100) groups. The presence of Arterial Microcalcification (AMC) was confirmed through pathologic examination of arterial specimens obtained during vascular access surgery, using von Kossa staining. This allowed researchers to correlate the CACS with the presence of AMC.

4

What were the key findings of the study, and what do they imply for patient care?

A key finding was that a high Coronary Artery Calcium Score (CACS) was associated with a higher incidence of Arterial Microcalcification (AMC). Patients with a CACS of 100 or greater were more likely to have AMC compared to those with a score below 100. The implication of this correlation is that assessing CACS could help predict the risk of AMC in hemodialysis patients. This allows healthcare providers to proactively manage vascular access health and potentially prevent complications, ultimately improving patient outcomes and quality of life.

5

What are the implications of this research for hemodialysis patients and their care?

This research suggests that monitoring Coronary Artery Calcification (CAC) via the Coronary Artery Calcium Score (CACS) can be a valuable tool for managing vascular access in hemodialysis patients. By identifying individuals with a high CACS, healthcare providers can take proactive steps to preserve the health of the vascular access. This might include implementing targeted interventions to manage CAC or other risk factors associated with Arterial Microcalcification (AMC). Further research is needed to determine the best strategies for managing CAC and preventing AMC and to improve long-term outcomes for patients undergoing hemodialysis. Early detection with less invasive methods allows for earlier intervention to preserve vascular access health.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.